PMS productivity loss: how PMS and PMDD affect work

PMS itself is common. How often it costs a woman a day's work is a separate, less-studied question.

A 2025 review of 31 nutrition trials cites a global PMS prevalence of about 48% as background context. That figure isn't from the review's own analysis: its 3,254 participants were women already enrolled in PMS-treatment trials, not a representative population sample.

The Cochrane review of GnRH analogues for PMS cites a working range of 20% to 30% of women of reproductive age for PMS, and three to eight percent for PMDD, the more severe form (see what counts as PMS versus a PMDD diagnosis). A 2020 meta-analysis pooling nine studies from Ethiopia found a PMS prevalence of 53% in that population.

None of these numbers separate out who loses work time from who doesn't. They count anyone with physical or emotional symptoms before a period, whether or not it costs them a shift, a deadline or a hard meeting.

• Global background citation: about 48% (2025 nutrition RCT review; not the review's own 3,254-woman sample)
• Cochrane's working range: 20% to 30% for PMS, 3% to 8% for PMDD
• Ethiopia pooled estimate: 53% (2020 meta-analysis, nine studies)
• Nursing students pooled estimate: 62% for PMS, 21% for PMDD or severe PMS (2025 meta-analysis, n=5,131)

Even the lower end of that range, about one in five women, is a lot of workdays riding on a week every month that most workplaces don't plan around.

The largest, most tightly designed studies look past how many women have PMS, toward what it actually costs them at work.

A 2025 meta-analysis pooling 20 studies in 5,131 nursing students found 62% had PMS and 21% had PMDD or severe PMS; the included research also reported absenteeism and reduced clinical performance.

A Japanese cohort of 222 women, tracked for three months after starting a hormonal contraceptive for perimenstrual symptoms, found work productivity impairment improved by 20% within the first month and stayed down through month three.

A registered trial protocol outlines plans to test a period-tracking app against a waitlist, with work productivity and absenteeism as planned outcomes in women with moderate to severe PMS or PMDD; results aren't published yet. Every figure below comes from our research library.

The same pattern, higher numbers in specific groups and lower ones in general-population surveys, turns up by age and country too.

Nursing students, who combine clinical placements with coursework, report PMS at 62% and PMDD or severe PMS at 21%, well above the 48% background figure cited in the 2025 nutrition review.

The 2020 Ethiopia meta-analysis found 53% among women of reproductive age there, pooling nine local studies rather than one global sample. Cochrane's broader range of 20% to 30% for PMS sits lower still, because it draws on a wider set of populations and definitions rather than one high-demand group. See the full PMS prevalence numbers for how these figures compare across more studies.

• Nursing students: 62% PMS, 21% PMDD or severe PMS
• Background citation, reproductive age: about 48% (not pooled data)
• Ethiopia specifically: 53%
• Broad working range across populations: 20% to 30% PMS, 3% to 8% PMDD

Country and age don't change the biology much. They change who got surveyed, and how.

Four things drive most of the gap between a 20% estimate and a 62% one.

• Definition: a broad symptom checklist counts far more people than a confirmed PMDD diagnosis, which needs five symptoms, one of them mood-related, tracked daily across two cycles.
• Population: students and clinic patients tend to report more symptoms than random population samples, partly because they're already paying closer attention to their cycle.
• Measurement: a single retrospective questionnaire ('did you have PMS last month?') usually produces a higher number than two cycles of daily tracking, because memory tends to round up the premenstrual days.
• Country and healthcare context: where and how a study recruits its sample changes who shows up in it.

A single percentage, quoted without its method, tells you less than it looks like it does.

No single percentage tells you whether your own month at work is harder than it should be. What matters is whether the pattern repeats: the same days, the same drop in focus or patience, easing once your period starts.

If PMS is costing you at work most months, start by writing down what happens and when, for two full cycles. That turns a feeling into a pattern you, or a doctor, can actually look at.

The fuller PMDD prevalence picture and how PMDD is diagnosed cover what counts as a diagnosis versus one month that felt off. A pattern that costs you the same week every month, across six or more cycles, is worth writing down before it turns into background noise.

Niyora is a PMS and PMDD support app. If you can feel your focus sliding mid-afternoon, Niyora's Moon lets you note what's happening, check your estimated PMS window and decide what to do next before you send an email you'll regret.

If this costs you a week of work every month, or you have thoughts of hurting yourself, see a GP or gynecologist and bring two months of daily notes.